Computer-aided selection of potential antihypertensive compounds with dual mechanism of action

被引:40
作者
Lagunin, AA [1 ]
Gomazkov, OA [1 ]
Filimonov, DA [1 ]
Gureeva, TA [1 ]
Dilakyan, EA [1 ]
Kugaevskaya, EV [1 ]
Elisseeva, YE [1 ]
Solovyeva, NI [1 ]
Poroikov, VV [1 ]
机构
[1] Russian Acad Med Sci, Inst Biol Chem, Moscow 119121, Russia
关键词
D O I
10.1021/jm021089h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The prediction of biological activity spectra for substances as an approach for searching compounds with complex mechanisms of action was studied. New compounds with dual mechanisms of antihypertensive action were found by this approach. Biological activity spectra for substances were predicted on the basis of their structural formulas by the computer program PASS. Thirty molecular mechanisms of action of compounds from the MDDR 99.2 database, which cause the antihypertensive effect and can be predicted by PASS, have been identified. The analysis of predictions for compounds with 15 dual antihypertensive mechanisms of action from the MDDR 99.2 database has confirmed high accuracy of prediction. This approach was applied to databases of commercially available compounds (AsInEx and ChemBridge) and allowed us to select four substances that are potential inhibitors of angiotensin converting enzyme (ACE) and of neutral endopeptidase (NEP). At a later time, all these compounds were found to be the inhibitors of both ACE and NEP. The most potent compounds had IC50 of 10(-7)-10(-9) M for ACE and 10(-5) M for NEP. New combinations of dual mechanisms of action never before found for antihypertensive compounds were predicted.
引用
收藏
页码:3326 / 3332
页数:7
相关论文
共 42 条
  • [1] Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS)
    Anzali, S
    Barnickel, G
    Cezanne, B
    Krug, M
    Filimonov, D
    Poroikov, V
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (15) : 2432 - 2437
  • [2] Apostolakis J, 1999, COMB CHEM HIGH T SCR, V2, P91
  • [3] AZARYAN AV, 1989, PEPTIDHYDROLASES NER, P8
  • [4] Angiotensin-converting enzyme inhibition to enhance vascular health-clinical and research models
    Bakris, GL
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (08) : 264S - 269S
  • [5] BARRETT RJ, 1991, J CARDIOVASC PHARM, V17, P134, DOI 10.1097/00005344-199101000-00019
  • [6] Beaumont A, 1996, ZINC METALLOPROTEASE, P105
  • [7] BELYAEV N A, 1990, Biokhimiya, V55, P1778
  • [8] CORVOL P, 1995, METHOD ENZYMOL, V248, P283
  • [9] Duncan AM, 1999, J PHARMACOL EXP THER, V289, P295
  • [10] ELISEEVA YE, 1976, VOP MED KHIM, V22, P81